Cockatiel with Chronic Regurgitation and Weight Loss Despite Good Appetite

This is a classic and unfortunately common presentation in cockatiels, highlighting the challenges of chronic gastrointestinal issues in psittacines. The constellation of chronic regurgitation, progressive weight loss despite a good appetite, undigested seeds, crop dilation, and proventricular dilation immediately brings two primary differentials to mind: Avian Gastric Yeast (Macrorhabdus ornithogaster, formerly Megabacteria) and Proventricular Dilatation Disease (PDD). Given the proventricular dilation on radiographs, PDD is a significant concern, but Macrorhabdus can also lead to secondary dilation due to severe maldigestion and stasis. A bacterial or fungal crop infection is less likely as a primary cause given the chronicity and proventricular involvement, but secondary infections are always a possibility. The fact that the other birds are currently asymptomatic doesn't rule out an infectious etiology, as clinical signs can vary.

My diagnostic plan would start with non-invasive but critical tests. First, a crop wash with cytology and a Gram stain, looking specifically for the characteristic large, gram-positive rod-shaped Macrorhabdus organisms, as well as any other significant bacterial populations or yeast. A direct fecal wet mount and Gram stain are also essential to assess for undigested food and Macrorhabdus in the lower GI tract. Blood work (CBC and chemistry panel) will provide insight into systemic health, hydration, inflammation, and organ function, especially liver and kidney values, and total protein, which I suspect will be low given the malabsorption.

If PDD is suspected, which it strongly is with proventricular dilation, a PCR test on a cloacal swab or proventricular biopsy for Avian Bornavirus (ABV) is warranted. However, a negative PCR doesn't definitively rule out PDD as shedding can be intermittent. The gold standard for PDD diagnosis remains histopathology of a proventricular or ventricular biopsy showing lymphoplasmacytic ganglioneuritis, ideally obtained via endoscopy, which also allows visual assessment of the mucosa. While waiting for definitive results, I would initiate supportive care, including environmental warmth, easy-to-digest hand-feeding formula if the bird is truly cachectic, and consider empirical treatment for Macrorhabdus and symptomatic support for motility issues.

While avian medicine isn't my primary wheelhouse, the principles of managing chronic gastrointestinal disease with weight loss despite a good appetite are quite similar to what we see in feline practice, such as cases of chronic enteropathy or even gastrointestinal lymphoma. The immediate take-home message for me, regardless of species, is that this bird is in a critical state due to significant weight loss. My primary concern would be stabilizing the patient while pursuing diagnostics.

I completely agree with Dr. Kessler's initial diagnostic approach, particularly the crop wash and fecal analysis. These are quick, relatively inexpensive, and provide immediate, actionable information without being invasive. In feline medicine, we also heavily rely on fecal exams for parasites, bacterial imbalances, and maldigestion, and I see the direct parallel here. The blood work for general health and hydration status is paramount. For a cat with chronic regurgitation and weight loss, I'd certainly be checking electrolytes, albumin, and a full chemistry panel to assess for systemic effects and underlying metabolic derangements. I'd also emphasize the importance of monitoring hydration and providing subcutaneous fluids (e.g., LRS at 50 mL/kg/day, divided if needed, or based on dehydration assessment) if any dehydration is noted, which is likely with chronic regurgitation.

For initial management, while the diagnostics are pending, I would focus on nutritional support. If the bird can still eat, offering a highly digestible, softened pelleted diet or even a gruel form. If not, assisted feeding with a recovery formula would be critical. Regarding empiric treatment, while I appreciate Dr. Kessler's focus on Macrorhabdus, in a feline patient with chronic vomiting and weight loss, I might also be inclined to include a broad-spectrum antibiotic empirically, like a penicillin derivative or metronidazole, to cover for potential bacterial overgrowth or dysbiosis, especially if there's any evidence of secondary infection on cytology. However, I understand the avian world has different sensitivities and primary pathogens, and I would defer to Dr. Kessler's expertise on the most appropriate initial empiric antimicrobial given the specific avian differentials. For the proventricular dilation, I'd definitely lean into prokinetics early on to try and improve GI motility.

From a pharmacology standpoint, this case presents several opportunities for targeted, yet careful, therapeutic intervention. Assuming we follow Dr. Kessler's and Dr. Anand's advice regarding diagnostics, let's discuss the medications mentioned. If Macrorhabdus ornithogaster is suspected or confirmed, Amphotericin B suspension is the first-line drug. It's crucial to remember that oral Amphotericin B is virtually non-absorbed from the GI tract, making it ideal for localized luminal infections. The dose is typically 100-250 mg/kg orally two to three times daily for 30 days. Precision in dosing is absolutely critical for a 78g cockatiel; errors can lead to inefficacy or potential side effects if inadvertently absorbed or aspirated. It must be a specific compounded suspension, as human IV formulations are highly nephrotoxic and inappropriate. Owners need clear instructions on administration to minimize aspiration risk.

For proventricular dilation and motility issues, metoclopramide is a reasonable choice, typically dosed at 0.5-1 mg/kg orally two to three times daily. It acts as a D2 dopamine receptor antagonist and 5-HT4 serotonin receptor agonist, promoting upper GI motility. While well-tolerated in many birds, CNS side effects like ataxia or tremors are possible, though less common than in some mammalian species. If metoclopramide is insufficient, or if there's a concern for CNS effects, cisapride (0.5-2 mg/kg PO BID-TID) could be an alternative. It primarily works via 5-HT4 agonism, stimulating motility without D2 antagonism, thus typically having fewer CNS effects, but its availability requires compounding.

Regarding Dr. Anand's suggestion of an empirical broad-spectrum antibiotic, while I appreciate the rationale, I'd strongly caution against it unless there's clear cytologic evidence of a significant bacterial component or septicemia. Unnecessary antibiotic use can exacerbate GI dysbiosis, especially in a bird already suffering from maldigestion. If an antibiotic is deemed necessary, based on culture or high suspicion of a specific pathogen, my choice would depend on the suspected bacteria. For instance, doxycycline (5-10 mg/kg PO BID) is effective for some GI bacteria and Chlamydia, but must be given with food or flushed well to prevent esophageal irritation. Enrofloxacin (10-15 mg/kg PO BID) is another option with broad-spectrum activity and good tissue penetration. However, definitive diagnosis should always guide antibiotic selection to avoid resistance. Finally, if PDD is strongly suspected, NSAIDs like meloxicam (0.2-0.5 mg/kg PO SID-BID) could be used to manage pain and inflammation, but always with caution regarding potential renal and GI side effects, especially in a dehydrated or debilitated bird. Baseline renal values are advisable before starting chronic NSAID therapy.